Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas

Acta Neuropathologica

Volumn 94, Issue 4, 1997, Pages 303-309

  Biernat, Wojciech ^a   Tohma, Yasuo ^a   Yonekawa, Yasuhiro ^b   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CDK4; Glioblastoma; p16; Progression; RB

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CELL CYCLE; FEMALE; GENE DELETION; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; REGULATOR GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, CDC; GENES, P16; GENES, REGULATOR; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 0030881477     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050711     Document Type: Article

References (53)

1. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR, Wahl GM (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A 92:5436-5440
2. Berry DE, Lu Y, Schmidt B, Fallon PG, O'Connell C, Hu SX, Xu HJ, Blanck G (1996) Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene 12:1809-1819
3. Biernat W, Kleihues P, Yonekawa Y, Ohgaki H (1997) Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J Neuropathol Exp Neurol 56:180-185
4. Brustle O, Ohgaki H, Schmitt HP, Walter GF, Ostertag H, Kleihues P (1992) Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer 69:2385-2392
5. Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105
6. Burger PC, Scheithauer BW (1994) Tumors of the Central Nervous System. Armed Forces Institute of Pathology, Washington
7. Cairns P, Proctor AJ, Knowles MA (1991) Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6:2305-2309
8. Costello JF, Berger MS, Huang H-JS, Cavenee WK (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56:2405-2410
9. Daumas Duport C, Scheithauer B, O'Fallon J, Kelly P (1988) Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152-2165
10. Fan G, Ma X, Kren BT, Steer CJ (1996) The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 12:1909-1919
11. Feugeas O, Guriec N, Babin Boilletot A, Marcellin L, Simon P, Babin S, Thyss A, Hofman P, Terrier P, Kalifa C, Brunat Mentigny M, Patricot LM, Oberling F (1996) Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 14:467-472
12. Giani C, Finocchiaro G (1994) Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 54:6338-6339
13. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302
14. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL. Brambilla C (1994) Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 58:818-824
15. Grana X, Reddy P (1995) Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11:211-219
16. Haas Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, Israel MA (1995) Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14:461-472
17. He J, Olson JJ, James CD (1995) Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55:4833-4836
18. IKA4a gene is associated with amplification of the EGF receptor gene in glioblastomas. Int J Cancer (in press)
19. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714-721
20. Horowitz JM, Yandell DW, Park SH, Canning S, Whyte P, Buchkovich K, Harlow E, Weinberg RA, Dryja TP (1989) Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937-940
21. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13:1065-1072
22. Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A, Johnson BE (1995) Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst 87:756-761
23. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255-268
24. Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA, Bruner J (1996) Mutations of the p16 gene in gliomas. Oncogene 12:63-67
25. Lantos PL, VandenBerg SR, Kleihues P (1996) Tumours of the Nervous System. In: Graham DI, Lantos PL(eds) Greenfield's Neuropathology, vol 9, 6th edn. Arnold, London, pp 583-879
26. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294
27. Lipponen PK, Liukkonen TJ (1995) Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. J Cancer Res Clin Oncol 121:44-50
28. Ludlow JW, DeCaprio JA, Huang CM, Lee WH, Paucha E, Livingston DM (1989) SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65
29. Morgan DO (1995) Principles of CKD regulation. Nature 374: 131-134
30. Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B (1995) MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 146:613-619
31. Neubauer A, Neubauer B, He M, Effert P, Iglehart D, Frye RA, Liu E (1992) Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene 7:1019-1025
32. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N (1995) Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 83:32-36
33. Ohgaki H, Schauble B, zur Hausen A, von Ammon K, Kleihues P (1995) Genetic alterations associated with the evolution and progression of astrocytic brain tumours. Virchows Arch 427:113-118
34. Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN (1996) Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 55:1026-1031
35. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375-3378
36. Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjanen K (1995) Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 31A:329-333
37. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299-4303
38. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A (1996) Amplification of the cyclin-dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 92:70-74
39. Sakaguchi M, Fujii Y, Hirabayashi H, Yoon HE, Komoto Y, Oue T, Kusafuka T, Okada A, Matsuda H (1996) Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study. Int J Cancer 65:442-445
40. Scherer HJ (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40:159-198
41. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54:6321-6324
42. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 336:704-707
43. INK4 expression in primary lung cancers and cell lines. Cancer Res 55:505-509
44. INK4 gene in human glioma cells. Oncogene 12:2029-2034
45. Tachibana O, Lampe K, Kleihues P, Ohgaki H (1996) Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of the glioblastoma multiforme. Acta Neuropathol 92:431-434
46. Tamimi Y, Bringuier PP, Smit F, Van Bokhoven A, Abbas A, Debruyne FMJ, Schalken JA (1996) Homozygous deletions of p16INK4 occur frequently in bilharziasis associated bladder cancer. Int J Cancer 68:183-187
47. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Naka-mura M (1996) Alterations of retinoblastoma, p53, p16 (CDKN2), and p15 genes in human astrocytomas. Cancer 78:287-293
48. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56:150-153
49. Ueki K, Rubio M-P, Ramesh V, Correa KM, Rutter JL, von Deimling A, Buckler AJ, Gusella JF, Louis DN (1994) MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3:1841-1845
50. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M (1995) Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 55:20-23
51. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217-224
52. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323-330
53. Yeager T, Stadler W, Belair C, Puthenveettil J, Olopade O, Reznikoff C (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res 55:493-497